Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism ARG1 inhibitors(Arginase-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anemia, Sickle Cell | Preclinical | Poland | 15 Jan 2024 | |
| Endothelial dysfunction | Preclinical | Poland | 15 Jan 2024 | |
| Pulmonary Arterial Hypertension | Preclinical | Poland | 15 Jan 2024 | |
| Reperfusion Injury | Preclinical | Poland | 15 Jan 2024 |





